Canopy Growth International Medical Cannabis Revenue Doubles In Q1, But What About Net Sales?

Canopy Growth Corporation CGC WEED released its financial results for the first quarter ended June 30, 2022, revealing net revenue of CA$110 million ($85.36 million) in Q1 FY2023 declined 19% versus Q1 FY2022.

Q1 Fiscal 2023 Financial Highlights

  • Q1 FY2023 net revenue was flat compared to Q4 FY2022.

  • International medical cannabis net revenue approximately doubled versus Q1 FY2022 driven primarily by strong sales in Israel and Australia.

  • Record BioSteel revenues in Q1 FY2023 increased 169% versus Q1 FY2022.

  • Reported gross margin in Q1 FY2023 was (1%) as compared to 20% in Q1 FY2022.

  • Total SG&A expenses in Q1 FY2023 declined by 8% versus Q1 FY2022, driven by year-over-year reductions in general & administrative and research and development expenses, offset by increases in sales and marketing.

  • Net loss in Q1 FY2023 was CA$2,088 million, which is a CA$2,478 million increase in the net loss versus Q1 FY2022, driven primarily by the non-cash CA$1,725 million impairment in goodwill, and non-cash fair value changes.

  • Adjusted EBITDA loss in Q1 FY2023 was CA$75 million, an CA$11 million increase in adjusted EBITDA loss versus Q1 FY2022 primarily driven by the decline in gross margin, partially offset by the reduction in our total SG&A expenses.

  • Cash and short-term investments amounted to CA$1.2 billion at June 30, 2022, representing a decrease of CA$0.2 billion from CA$1.4 billion at March 31, 2022.

  • Cost reduction program on track with operating expenses in Q1 FY2023 decreasing by 13% versus Q1 FY2022.

David Klein, CEO sated, "Through advancements in our North American brand led strategy we delivered a record quarter from BioSteel and maintained #1 share in the premium flower and pre-rolled joint segment, while driving growth of our premium Doja and mainstream Tweed brands. As our U.S. THC ecosystem continues to strengthen with Acreage operating in the recreational cannabis market in New Jersey, along with the expansion of Wana across North America, we remain focused on delivering a robust pipeline of innovation aligned to what consumers are looking for – premium, infused, and ready to enjoy."

Photo: Benzinga; Sources: courtesy of Kindel Media via Pexels

Related New

Canopy Growth Taps Ex Aphria Executive Christelle Gedeon As New Chief Legal Officer

Canopy Growth's 7ACRES And Doja Launching New Cannabis Products

ScottsMiracle-Gro, TerrAscend, Canopy Growth & Other Large Cannabis Stocks Announce Earnings Release Dates

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksSmall CapMarketsDavid Klein
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.